Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.96
(0.51%)
CAD 1.96
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 78.76 Thousand | - | - | - |
| Cost of Revenue | 248.35 Thousand | 219.9 Thousand | - | 229.53 Thousand | 150.57 Thousand | 91.49 Thousand |
| Gross Profit | -248.35 Thousand | -219.9 Thousand | 78.76 Thousand | -229.53 Thousand | -150.57 Thousand | -91.49 Thousand |
| Operating Expenses | 29.53 Million | 41.33 Million | 38.74 Million | 20.69 Million | 14.12 Million | 7.49 Million |
| Selling, General and Administrative Expenses | 15.56 Million | 22.37 Million | 27.87 Million | 9.94 Million | 10.44 Million | 5.86 Million |
| Research and Development Expenses | 14.22 Million | 18.96 Million | 10.87 Million | 10.51 Million | 3.53 Million | 1.53 Million |
| Other Expenses | - | 164.44 Thousand | 112.22 Thousand | 229.53 Thousand | 150.57 Thousand | 91.49 Thousand |
| Cost and Expenses | 29.78 Million | 41.33 Million | 38.74 Million | 20.69 Million | 14.12 Million | 7.49 Million |
| Operating Income | -29.78 Million | -50.33 Million | -45.47 Million | -20.6 Million | -13.58 Million | -7.49 Million |
| Interest Expense | - | - | - | - | 621.00 | 663.37 Thousand |
| Income Tax Expense | 1.00 | -19.4 Million | -6.91 Million | 7398.00 | 299.41 Thousand | -7.73 Million |
| Earnings before Tax | -28.12 Million | -30.93 Million | -31.63 Million | -20.64 Million | -13.68 Million | -15.89 Million |
| Net Income | -28.12 Million | -11.52 Million | -24.72 Million | -20.64 Million | -13.98 Million | -15.89 Million |
| Earnings Per Share Basic | -0.44 | -0.18 | -0.57 | -0.69 | -0.54 | -1.03 |
| Earnings Per Share Diluted | -0.44 | -0.18 | -0.57 | -0.69 | -0.54 | -1.03 |
| Weighted Average Shares Outstanding | 64.46 Million | 62.5 Million | 43.22 Million | 29.85 Million | 25.82 Million | 15.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.46 Million | 62.5 Million | 43.22 Million | 29.85 Million | 25.82 Million | 15.37 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | -574.56 | - | - | - |
| Profit Margin | - | - | -313.91 | - | - | - |
| EBITDA | -27.87 Million | -30.71 Million | -38.44 Million | -20.41 Million | -13.53 Million | -15.13 Million |
| Earnings Before Tax Margin | - | - | -577.36 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 61.9 Thousand | 61.62 Thousand | 66.76 Thousand | 248.35 Thousand | 64.89 Thousand | 58.49 Thousand |
| Gross Profit | -61.9 Thousand | -61.62 Thousand | -66.76 Thousand | -248.35 Thousand | -64.89 Thousand | -58.49 Thousand |
| Operating Expenses | 7.67 Million | 8.34 Million | 7.96 Million | 29.53 Million | 7.65 Million | 6.31 Million |
| Selling, General and Administrative Expenses | 4.96 Million | 5.02 Million | 3.92 Million | - | 5.07 Million | 2.83 Million |
| Research and Development Expenses | 2.7 Million | 3.32 Million | 4.04 Million | - | 2.57 Million | 3.47 Million |
| Other Expenses | - | 28.22 Thousand | - | - | 149.73 Thousand | - |
| Cost and Expenses | 7.74 Million | 8.4 Million | 8.02 Million | 29.78 Million | 7.65 Million | 6.31 Million |
| Operating Income | -7.74 Million | -8.4 Million | -8.02 Million | -29.78 Million | -8.71 Million | -4.62 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 2.00 | -2.00 | -2.00 | 5.00 | -1.57 Million | 1.15 Million |
| Earnings before Tax | -6.59 Million | -9.17 Million | -7.63 Million | -28.12 Million | -5.93 Million | -7.47 Million |
| Net Income | -6.59 Million | -9.17 Million | -7.63 Million | -28.12 Million | -5.93 Million | -7.47 Million |
| Earnings Per Share Basic | -0.10 | -0.14 | -0.12 | - | -0.09 | -0.12 |
| Earnings Per Share Diluted | -0.10 | -0.14 | -0.12 | - | -0.09 | -0.12 |
| Weighted Average Shares Outstanding | 68.75 Million | 67.25 Million | 65.35 Million | 64.46 Million | 64.48 Million | 64.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.75 Million | 67.25 Million | 65.35 Million | 64.46 Million | 64.48 Million | 64.1 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -7.67 Million | -8.34 Million | -7.96 Million | - | -8.65 Million | -4.57 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
0VAG
THS
KVIKA
FMAN
RATEGAIN
KSCP